Plasmacytoid dendritic cells infiltrating ovarian cancer are associated with poor prognosis

被引：118

作者：

Labidi-Galy, Sana Intidhar ^{[1
,2
,3
,4
,5
,6
]}

Treilleux, Isabelle ^{[7
]}

Goddard-Leon, Sophie ^{[7
]}

Combes, Jean-Damien ^{[8
]}

Blay, Jean-Yves ^{[1
,2
,3
,4
,5
,6
]}

Ray-Coquard, Isabelle ^{[6
]}

Caux, Christophe ^{[1
,2
,3
,4
,5
]}

Bendriss-Vermare, Nathalie ^{[1
,2
,3
,4
,5
]}

机构：

[1] Univ Lyon, Lyon, France

[2] Univ Lyon 1, ISPB, F-69365 Lyon, France

[3] INSERM, U1052, Ctr Rech Cancerol Lyon, F-69008 Lyon, France

[4] CNRS, UMR5286, Ctr Rech Cancerol Lyon, Lyon, France

[5] LabEx DEVweCAN, Lyon, France

[6] Ctr Leon Berard, Dept Med Oncol, F-69373 Lyon, France

[7] Ctr Leon Berard, Dept Biopathol, F-69373 Lyon, France

[8] Ctr Leon Berard, Dept Biostat, F-69373 Lyon, France

来源：

ONCOIMMUNOLOGY | 2012年 / 1卷 / 03期

关键词：

plasmacytoid dendritic cell; ovarian cancer; immune tolerance; prognosis; progression-free survival; CHRONIC MYELOID-LEUKEMIA; IMATINIB;

D O I：

10.4161/onci.18801

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Using two different and complementary approaches (flow cytometry and immunohistochemistry) on two independent cohorts of ovarian cancer patients, we found that accumulation of plasmacytoid dendritic cells (pDC) in tumors is associated with early relapse. This deleterious effect of tumor-associated pDC was evident when they are present in cancer epithelium but not in lymphoid aggregates.

引用

页码：379 / 381

页数：3

共 10 条

[1] Intraperitoneal α-interferon alternating with cisplatin in residual ovarian carcinoma:: A phase II Gynecologic Oncology Group study
Berek, JS
Markman, M
Blessing, JA
Kucera, PR
Nelson, BE
Anderson, B
Hanjani, P
[J]. GYNECOLOGIC ONCOLOGY, 1999, 74 (01) : 48 - 52
[2] Interferons, immunity and cancer immunoediting
Dunn, Gavin P.
Koebel, Catherine M.
Schreiber, Robert D.
[J]. NATURE REVIEWS IMMUNOLOGY, 2006, 6 (11) : 836 - 848
[3] Interferon-alpha regulates the dynamic balance between human activated regulatory and effector T cells: implications for antiviral and autoimmune responses
Golding, Amit
Rosen, Antony
Petri, Michelle
Akhter, Ehtisham
Andrade, Felipe
[J]. IMMUNOLOGY, 2010, 131 (01) : 107 - 117
[4] Impaired Toll-like receptor 7 and 9 signaling: from chronic viral infections to cancer
Hirsch, Ivan
Caux, Christophe
Hasan, Uzma
Bendriss-Vermare, Nathalie
Olive, Daniel
[J]. TRENDS IN IMMUNOLOGY, 2010, 31 (10) : 391 - 397
[5] Jensen T.O., 2011, Cancer
[6] Quantitative and Functional Alterations of Plasmacytoid Dendritic Cells Contribute to Immune Tolerance in Ovarian Cancer
Labidi-Galy, Sana Intidhar
Sisirak, Vanja
Meeus, Pierre
Gobert, Michael
Treilleux, Isabelle
Bajard, Agathe
Combes, Jean-Damien
Faget, Julien
Mithieux, Francois
Cassignol, Alexandre
Tredan, Olivier
Durand, Isabelle
Menetrier-Caux, Christine
Caux, Christophe
Blay, Jean-Yves
Ray-Coquard, Isabelle
Bendriss-Vermare, Nathalie
[J]. CANCER RESEARCH, 2011, 71 (16) : 5423 - 5434
[7] Imatinib and plasmacytoid dendritic cell function in patients with chronic myeloid leukemia
Mohty, M
Jourdan, E
Ben Mami, N
Vey, N
Damaj, G
Blaise, D
Isnardon, D
Olive, D
Gaugler, B
[J]. BLOOD, 2004, 103 (12) : 4666 - 4668
[8] Imatinib plus Peginterferon Alfa-2a in Chronic Myeloid Leukemia.
Preudhomme, Claude
Guilhot, Joelle
Nicolini, Franck Emmanuel
Guerci-Bresler, Agnes
Rigal-Huguet, Francoise
Maloisel, Frederic
Coiteux, Valerie
Gardembas, Martine
Berthou, Christian
Vekhoff, Anne
Rea, Delphine
Jourdan, Eric
Allard, Christian
Delmer, Alain
Rousselot, Philippe
Legros, Laurence
Berger, Marc
Corm, Selim
Etienne, Gabriel
Roche-Lestienne, Catherine
Eclache, Virginie
Mahon, Francois-Xavier
Guilhot, Francois
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (26) : 2511 - 2521
[9] SISIRAK V, 2008, 10 INT S DENDR CELLS
[10] Plasmacytoid dendritic cells and cancer
Vermi, William
Soncini, Matias
Melocchi, Laura
Sozzani, Silvano
Facchetti, Fabio
[J]. JOURNAL OF LEUKOCYTE BIOLOGY, 2011, 90 (04) : 681 - 690

← 1 →